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Abstract 22 
In previous work (1, 2), we demonstrated that Escherichia coli could acquire substantial levels of 23 
resistance to ionizing radiation (IR) via directed evolution. Major phenotypic contributions 24 
involved adaptation of organic systems for DNA repair. We have now undertaken an extended 25 
effort to generate Escherichia coli populations that are as resistant to IR as Deinococcus 26 
radiodurans. After an initial 50 cycles of selection using high-energy electron beam IR, four 27 
replicate populations exhibit major increases in IR resistance, but have not yet reached IR 28 
resistance equivalent to D. radiodurans. Regular deep sequencing reveals complex evolutionary 29 
patterns with abundant clonal interference. Prominent IR resistance mechanisms involve novel 30 
adaptations to DNA repair systems, and alterations in RNA polymerase. Adaptation is highly 31 
specialized to resist IR exposure, as isolates from the evolved populations exhibit highly variable 32 
patterns of resistance to other forms of DNA damage. Sequenced isolates from the populations 33 
possess between 184 and 280 mutations. IR resistance in one isolate, IR9-50-1, is derived largely 34 
from four novel mutations affecting DNA and RNA metabolism: RecD A90E, RecN K429Q, 35 
and RpoB S72N/RpoC K1172I. Additional mechanisms of IR resistance are evident. 36 
 37 
Importance 38 
Some bacterial species exhibit astonishing resistance to ionizing radiation, with Deinococcus 39 
radiodurans being the archetype. As natural IR sources rarely exceed mGy levels, the capacity of 40 
Deinococcus to survive 5,000 Gy has been attributed to desiccation resistance. To understand the 41 
molecular basis of true extreme IR resistance, we are using experimental evolution to generate 42 
strains of Escherichia coli with IR resistance levels comparable to Deinococcus. Experimental 43 
evolution has previously generated moderate radioresistance for multiple bacterial species. 44 
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However, these efforts could not take advantage of modern genomic sequencing technologies. In 45 
this report, we examine four replicate bacterial populations after 50 selection cycles. Genomic 46 
sequencing allows us to follow the genesis of mutations in populations throughout selection. 47 
Novel mutations affecting genes encoding DNA repair proteins and RNA polymerase enhance 48 
radioresistance. However, more contributors are apparent. 49 
 50 
Introduction 51 
Ionizing radiation (IR) can damage any cellular component, either through direct ionization by 52 
high energy photons and electrons, or indirect ionization from reactive oxygen species (ROS) 53 
produced by radiolysis of water molecules. Fortunately, levels of IR sufficient to cause 54 
widespread oxidation of proteins or extensive DNA damage (including double strand breaks) are 55 
rarely encountered in the environment. Surprisingly, a number of microbial species and a few 56 
multicellular organisms have evolved extreme resistance to IR (3, 4). The bacterium 57 
Deinococcus radiodurans is the first-discovered and remains the best-studied example of this 58 
extremophile phenotype. D. radiodurans survives exposure to 5,000 Gray (Gy) of IR with no 59 
lethality, 1000-times the lethal dose for a human. In the case of this bacterium, extreme IR 60 
resistance appears to be a byproduct of natural selection for desiccation tolerance (5-7). D. 61 
radiodurans is not alone. Organisms with high levels of IR resistance can be found readily, 62 
particularly in arid environments (8, 9). 63 
IR resistance in D. radiodurans has been attributed in large measure to an enhanced 64 
capacity to ameliorate ROS produced by IR using a variety small molecules and metabolites (10-65 
12). D. radiodurans possesses a fairly standard complement of DNA repair systems. However, 66 
specialized adaptations of those systems and the evolution of a few novel DNA metabolic 67 
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functions may contribute substantially to the extraordinary capacity of D. radiodurans to repair 68 
an extensively damaged genome (13-15).  69 
 Substantial increases to bacterial IR resistance can be generated in the laboratory by 70 
directed evolution (16-19). The advent of advanced DNA sequencing technologies that reveal 71 
genomic changes in populations has revolutionized studies of molecular evolution. Mutational 72 
trajectories associated with adaptation have been defined in bacteria (20-26), viruses (27-31), 73 
yeast (32, 33), and mammalian tumors (34-45). These studies have greatly enhanced the 74 
experimental foundation of many phenomena predicted by evolutionary biology, including 75 
clonal interference (22, 24, 33),  diminishing returns epistasis (20, 46), and genetic parallelism 76 
(21-24, 26, 29). 77 
We have utilized directed evolution as a tool providing a facile path to a better 78 
understanding of mechanisms underlying the extreme IR resistance phenotype in bacteria. We 79 
previously exposed four replicate populations of Escherichia coli to 20 iterative rounds of 80 
gamma-ray IR and observed significant increases in IR resistance (1). Focusing on isolates from 81 
each population, we determined that IR resistance arose from enhanced DNA repair (reflected in 82 
mutant alleles of the recombinase RecA, replicative helicase DnaB, putative helicase YfjK, and 83 
replication restart machinery), and changes in the regulation of central metabolism and cellular 84 
responses to oxidative damage (through an allele of the anaerobic metabolism transcription 85 
factor, FNR) (1, 2, 47).  86 
 The overall IR resistance of these populations, while increased substantially, did not 87 
reach a level comparable to D. radiodurans. Efforts to further enhance the IR resistance 88 
phenotype have been constrained both by source decay (altering irradiation dose rate parameters 89 
and increasing times required to impose a particular dose on a sample) and by new governmental 90 
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policies mandating a general decommissioning of radioactive sources used for research. To 91 
generate D. radiodurans-like levels of IR resistance in evolved E. coli, we have embarked on a 92 
new and more ambitious effort with four new populations. This new effort employs a clinical 93 
linear accelerator (Linac) of a type utilized for radiation treatment of cancer patients. Using this 94 
device to produce a high energy electron beam, we can achieve a dose rate of 72 Gy/min, nearly 95 
4-fold higher than that used in the previous directed evolution study (1, 2). Use of this instrument 96 
eliminates the problem of radioactive source decay and greatly reduces the amount of time 97 
required for exposure to kGy levels of IR. The higher dose rate also allows us to explore 98 
adaptation to a potentially much more challenging IR environment than that utilized in earlier 99 
trials. We can also begin to assess the effect of dose rate on an evolution trial. 100 
 In this report, we characterize the four new E. coli lineages (IR9, IR10, IR11, and IR12) 101 
after the first 50 rounds of selection (IR9-50, IR10-50, IR11-50, and IR12-50). The dose required 102 
to kill 99% of the cells in each population has increased from approximately 750 Gy to over 103 
2000 Gy. These populations are highly resistant compared to the previously evolved isolates 104 
CB2000 and CB3000 (1, 2), which appear to be poorly adapted to the higher dose rates applied 105 
with the electron beam IR. Deep genomic sequencing of populations after every other selection 106 
cycle allow us to explore the full breadth of mutations and provides a revealing window on the 107 
evolution of IR resistance. To unveil IR resistance mechanisms, we focus on the genetic 108 
parallelism between the four lineages, as reflected in a representative isolate from population 109 
IR9-50, IR9-50-1. The results both reinforce some earlier conclusions and offer new insights. 110 
The phenotype in IR9-50-1 is largely explained by four mutations, none of which appeared in 111 
our previously evolved E. coli populations. Although adaptations in DNA repair machinery are 112 
again prominent, but now feature novel mutations in recD and recN which enhance IR 113 
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resistance. Furthermore, alterations in RNA polymerase (primarily variants in genes rpoB and 114 
rpoC) also contribute substantially to an IR resistant phenotype. The other three evolved 115 
populations exhibit patterns that both reinforce those seen in IR9-50 but also suggest direct 116 
competition of two distinct pathways of evolved IR resistance (through either paired mutations 117 
of the recA and recD genes, or a grouping of rpoB/C, recD, and recN). Further adaptation to IR 118 
(beyond the mutations described herein) has occurred in each of the four populations, and 119 
remains to be explored. 120 
 121 
Results 122 
High-energy electron beam IR kills E. coli at a similar rate to high-energy photon IR 123 
In this new set of evolution trials, we utilized a Linac to deliver doses with a high energy 124 
electron beam. Our previous evolution trials to generate IR resistant E. coli utilized a 
60
Co source 125 
with a dose rate of approximately 19 Gy/min (1). Using the Linac in electron mode, we were 126 
able to deliver the same doses at 72 Gy/min. As there is no source decay with this device, the 127 
dose rate will remain constant over the years required for an extended evolution trial. The dose 128 
delivered by the Linac was verified using thermoluminescent dosimeters (TLDs). The delivered 129 
dose varied by less than 5% of the calculated dose (Table S1). 130 
 Although the Linac electron beam and photon sources are different, the dose delivery 131 
mechanisms are very similar. In order to rule out any differences between electron and photon 132 
modes, we sought to determine if high-energy electron beam ionizing radiation (IR) kills E. coli 133 
similarly to high-energy photon IR. We note that the 
60
Co and 
137
Cs sources used in our previous 134 
directed evolution studies (1, 2, 47) produced high-energy photons. The Linac used in this study 135 
has both an electron and photon mode. By changing the distance of the E. coli cultures to the 136 
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source of the IR beam, the Gray per minute (Gy/min) dose rate can be made equivalent between 137 
these modes. At a dose rate of 17 Gy/min, high energy electrons and photons killed nearly an 138 
identical percentage of E. coli MG1655 culture at 1000 Gy, with the electron beam being slightly 139 
more potent (Fig. 1). Therefore, the two IR modes appear to have comparable effects at the level 140 
of bacterial survival.  141 
  142 
Directed evolution of extreme IR resistance over 50 rounds of selection 143 
Beginning with a single culture of the E. coli strain MG1655 split into four, we generated 144 
four IR resistant populations using a modified version of a previously established directed 145 
evolution protocol (1) as described in the Materials and Methods and depicted in Fig. 2A.  146 
Using this protocol, we carried out 50 iterative cycles (with selection cycles occurring 147 
approximately once per week). The resulting populations were designated IR9-50, IR10-50, 148 
IR11-50, and IR12-50 (Fig. 2B). Over these rounds of evolution, the dose required to kill 99% of 149 
each culture increased from approximately 750 to 2300 – 2500 Gy (Fig. 3A). At round 50, these 150 
populations were highly radioresistant compared to the parent MG1655 strain (Fig. 3B). 151 
Previously described IR resistant E. coli isolates (1, 2, 47), which were evolved to withstand 152 
60
Co IR at about 4-fold lower dose rates, were only moderately more resistant to the beam 153 
generated by the Linac compared to the parent strain and were greatly surpassed by the 154 
populations generated in this study (Fig. 3B). Populations IR9-50, IR10-50, IR11-50, and IR12-155 
50 have not yet reached the level of IR resistance of the bacterium Deinococcus radiodurans but 156 
have made significant progress towards this goal. We note that D. radiodurans was significantly 157 
more sensitive to the higher dose rate in the Linac electron source than it was to the lower dose 158 
rates in the 
60
Co photon source (Fig. 3B) (4, 11, 13). 159 
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 160 
Growth phenotypes of evolved population isolates 161 
The IR resistance phenotype of these experimentally-evolved populations was not 162 
accompanied by an apparent growth defect in LB rich medium. An isolate from each population 163 
at round 50 of selection (IR9-50-1, IR10-50-1, IR11-50-1, and IR12-50-1) produced growth 164 
curves comparable to the parent MG1655 strain in LB (Fig. 4A). However, growth defects of 165 
these isolates became apparent when inoculated in other growth media. In a defined rich medium 166 
supplemented with glucose, EZ medium, isolate IR12-50-1 failed to grow and isolates IR9-50-1 167 
and IR11-50-1 exhibited growth defects easily observed in a standard growth curve (Fig. 4B). 168 
The isolate IR10-50-1 grew similarly to MG1655 in EZ medium and was the only of the four 169 
isolates to grow in M9 minimal medium supplemented with glucose (Fig. 4C). Although IR9-50-170 
1, IR11-50-1, and IR12-50-1 have potentially inactivating mutations in key amino acid 171 
biosynthetic pathways that could prevent growth in minimal medium (IR10-50-1 does not have a 172 
mutation which would clearly affect amino acid biosynthesis), supplementing minimal medium 173 
with these amino acids did not rescue the ability of these isolates to grow (Fig. S1). 174 
Highly sensitive growth competition assays (48) in LB medium can reveal subtle growth 175 
phenotypes of these isolates that are not readily apparent when comparing standard growth 176 
curves (Fig. 5). When paired with the parent wild type E. coli strain in a mixed culture of LB, all 177 
four evolved isolates were rapidly outcompeted, even with significant dilutions to bias the 178 
starting culture ratios towards the evolved strains. These results indicated that 50 rounds of 179 
selection in this directed evolution protocol came with an underlying fitness cost, even when 180 
selection is not being applied. 181 
 182 
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Evolved isolates exhibit variable resistance to non-IR DNA damaging agents 183 
Isolates from the four evolved populations after 50 cycles of selection revealed that 184 
resistance to IR does not correlate in any predictable way with resistance to other DNA 185 
damaging agents, even within a single population (Fig. 6 and 7). Multiple isolates from each 186 
population exhibited highly variable levels of resistance to UV radiation (Fig. 6), mitomycin C 187 
(which causes DNA intrastrand crosslinks), ciprofloxacin (which causes DNA double-strand 188 
breaks through inhibition of DNA gyrase), bleomycin (which causes DNA double-strand breaks 189 
and apurinic/apyrimidinic sites through a ROS mediated mechanism (49, 50)), and hydroxyurea 190 
(which has a complex mechanism of action that both reduces dNTP production and causes ROS-191 
mediated DNA damage) (51-54)(Fig. 7). While some isolates exhibited increased resistance to 192 
these DNA-damaging agents, others showed no change or increased sensitivity. The results 193 
indicate that the directed evolution trials are generating specialists that are uniquely adapted to 194 
IR resistance. 195 
 196 
Deep-sequencing reveals unique evolutionary histories of the evolved populations 197 
We utilized deep-sequencing technology to monitor genomic changes as IR resistance increased 198 
with continued selection cycles. At every other round of selection, genomic DNA was prepared 199 
from each population and submitted to the Joint Genome Institute (Walnut Creek, CA) for 200 
sequencing to determine all mutations present in each population. Stitching together these 201 
snapshots revealed the underlying complexity of these evolving populations (Fig. 8A-D). 202 
Depicted in Fig. 8 are the allele frequencies of all mutations detected above 2% frequency at 203 
each even round of selection for each lineage. Each line represents a single mutation; groups of 204 
mutations that rise and fall in frequency together are inferred to be linked within a sub-205 
10 
 
population. The number of sub-populations and total number of mutations increased rapidly (Fig. 206 
8E). The steady accumulation of mutations over time suggests that mutator strains have not yet 207 
appeared in these populations. The complete dataset upon which Fig. 8 is based is provided in 208 
Supplementary Data 1 through 4. 209 
Despite starting from the same parent strain, the evolutionary path of each population was 210 
unique. The only event in common to each population was the excision of the e14 prophage, as 211 
indicated by four mutations in the icd gene in which the prophage is inserted (as depicted by the 212 
initial single black line appearing in each population in Fig. 8A-D). When e14 is excised, the icd 213 
gene is restored to the wild-type sequence. Despite excision of e14 occurring quickly in each 214 
population, that excision became fixed in only three of them. In the IR10 lineage, the sub-215 
population that lost the e14 prophage was driven extinct by another sub-population and e14 is 216 
retained in population IR10-50.  217 
Each lineage experienced significant clonal interference, as depicted by the numerous 218 
competing sub-populations in Fig. 8A-D. Competition of sub-populations within lineages IR11 219 
and IR12 significantly reduced the rate of fixation events in each lineage. In IR11 (Fig. 8C), no 220 
mutations were able to fix from approximately round 16 to round 50 of selection due to severe 221 
clonal interference. In IR12 (Fig. 8D), no subpopulation was able to sweep to fixation until 30 222 
cycles of selection were completed. Although clonal interference is apparent in lineages IR9 and 223 
IR10, its effects are far less severe than in IR11 and IR12. In IR9 (Fig. 8A), no subpopulation 224 
was able to fix post-e14 phage excision until approximately round 20. After this event, another 225 
subpopulation swept to fixation unimpeded (defined as a continuous, linear rate of increasing 226 
allele frequency). A final subpopulation was able to eventually reach 100% frequency, but was in 227 
competition with a separate subpopulation for approximately 12 rounds of selection. 228 
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Surprisingly, lineage IR10 (Fig. 8B) has approximately 6 distinct subpopulations which swept to 229 
fixation, and each was not noticeably affected by intra-population competition. The differing 230 
trajectories of evolution in each population may reflect the relative fitness of the mechanisms of 231 
IR resistance employed by each eventual successful subpopulation. 232 
At round 50 of selection, there were distinct differences in the amounts and types of 233 
mutations between populations. Populations IR9-50 and IR10-50 are the most homogenous, with 234 
approximately 16 and 17%, respectively, of the total high confidence (> 2% allele frequency) 235 
mutations being fixed (detected at > 99% frequency). In contrast, only 4% and 11% of high 236 
confidence mutations in IR11-50 and IR12-50 are fixed, respectively (Table 1). Although IR9-50 237 
and IR10-50 shared a similar percentage of fixed mutations, IR9-50 and IR12-50 had the highest 238 
total number of mutations. Each population had a ratio of non-synonymous to synonymous 239 
mutations greater than two. 240 
GC to AT and AT to GC transitions were detected in high numbers, agreeing with 241 
mutational patterns detected in previously evolved IR-resistant E. coli populations (1, 2). Base 242 
substitutions are approximately 50% transitions and 50% transversions, whereas E. coli exposed 243 
to 
60
Co gamma-ray irradiation exhibit transversions at about four times the frequency of 244 
transitions (1, 55). In particular, GC to TA transitions appeared at very high levels in each 245 
population, indicative of significant template-strand 8-oxodG-mediated mutagenesis (56). These 246 
results indicated that the selection utilized in the current study produces a substantially different 247 
mutational, and perhaps DNA damage, spectrum relative to the populations evolved to resist 248 
60
Co-produced IR. 249 
 250 
Mutations which enhance IR resistance in isolate IR9-50-1 251 
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We have begun characterization of evolved IR resistance after 50 cycles of selection. To 252 
define mutations that made significant contributions to the phenotype, we counted on a 253 
substantial degree of genetic parallelism (21, 22, 26) between the four populations. We focused 254 
on mutations meeting the following criteria: i) the mutations were non-synonymous; ii) 255 
mutations occurred in a gene that was mutated in at least two additional populations; iii) 256 
mutations in the gene achieved at least 10% abundance at some point during selection in each 257 
population in which they appeared; and iv) the mutation remained in the population at round 50 258 
of selection. These criteria narrowed the search to mutations appearing in six genes, including 259 
those involved in recombinational DNA repair (dinI, recD, and recN), transcription (rpoB), 260 
regulation of anaerobic metabolism (arcB), and copper ion transport (copA). Two additional gene 261 
alterations were analyzed: Nth C203Y and RecA A290S. These did not meet the criteria we set 262 
in the current study but were the only two variants, aside from the loss of the e14 prophage, 263 
where the exact same mutation appeared in two populations. The RecA A290S variant, which is 264 
fixed in population IR10-50 and also appears in the IR11 lineage, is the only variant detected in 265 
this current study that was also detected in an earlier study (1). The relevant variants are listed in 266 
Table 2. 267 
To determine the molecular basis of IR resistance in one of the populations, we more 268 
carefully characterized one isolate from population IR9-50: IR9-50-1. IR9-50-1 contained over 269 
300 mutations (Table 3). A complete dataset for mutations found within the sequenced isolates is 270 
presented in Supplementary Data 1 through 5, with isolate data in the appropriate lineage data 271 
file. 272 
IR9-50-1 is representative of several mutational patterns seen in most of the populations, 273 
as it has mutations in dinI, recD, recN, rpoB, rpoC, and copA (which contain the majority of 274 
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mutations listed in Table 2). This isolate does not have mutations in arcB, nth, and recA. 275 
However, a mutation in arcB, leading to the variant gene product ArcB N405D, did appear 276 
earlier in the IR9 lineage but was driven to extinction via clonal interference. As such, five 277 
protein variants present in IR9-50-1 were investigated for contributions to IR resistance: RecD 278 
A90E, RecN K429Q, DinI R28H, RpoB S72N, and CopA V270F. The ArcB N405D mutation 279 
was also examined as it represented a mutational pattern in other populations. A mutation in 280 
rpoC (which codes for the K1172I variant) was also included in the strains with RpoB S72N, as 281 
the genomic proximity of rpoC to rpoB did not allow for ready separation of these two mutations 282 
with the methods used here.  283 
To assess the potential contribution of mutations identified in this way to IR resistance, 284 
we first isolated each mutation in an otherwise wild-type genetic background. We then took the 285 
evolved isolate and converted the mutation being studied to wild-type in the otherwise mutant 286 
background to determine if it caused phenotypic loss. We moved these mutations singly and in 287 
combination into a derivative of the parent E. coli strain (MG1655) lacking the e14 prophage (as 288 
this prophage appears to excise from the chromosome after IR exposure and each subsequent 289 
mutation occurred in this genetic background (1, 2)). This strain, Founder Δe14 (1, 2), thus 290 
provided the otherwise wild-type genetic background to determine the contribution of each 291 
mutation to IR resistance. We determined that the RecD A90E and RpoB S72N/RpoC K1172I 292 
variants each provided a significant increase in IR resistance (Fig. 9A) when isolated in this 293 
otherwise wild type background. A combination of these two alleles did not significantly 294 
increase IR resistance of the parent strain beyond either individual mutation, indicating that they 295 
do not contribute additively. The effects of these two alleles were confirmed by converting each 296 
of them singly and in combinations to the wild-type allele in the IR9-50-1 genetic background 297 
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(Fig. 9B). Interestingly, the RecN K429Q mutation did not significantly alter IR resistance of 298 
Founder Δe14. However, when this variant was converted to the wild-type RecN in the IR9-50-1 299 
genetic background, IR resistance was dramatically lowered. When these four mutations were 300 
eliminated from a derivative of IR9-50-1 that retained the other 308 mutations, IR resistance was 301 
not reduced lower than the wild-type RecN single mutant, suggesting a key role for the RecN 302 
K429Q variant.  303 
The RecD A90E mutation appeared to be at least a partial loss of function, as deleting the 304 
recD gene from Founder Δe14 increased IR resistance just as much as the RecD A90E variant 305 
(Fig. 9A). These data agree with the fact that a truncated, and likely inactive, RecD variant 306 
appeared earlier in the IR9 lineage and in the IR10 lineage (Table 2). The DinI, CopA, and ArcB 307 
variants did not contribute significantly to IR resistance when isolated in the wild type 308 
background; additionally, converting the dinI or copA genes to the wild-type sequence in IR9-50-309 
1 did not increase IR sensitivity of this strain. 310 
Following the allele frequency of mutations in genes that demonstrably contributed to IR 311 
resistance (recA, recD, recN, and rpoB), a new pattern emerged (Fig. 10). In the lineages IR9, 312 
IR11, and IR12 there was a conserved temporal order in the appearance of mutations. First, the 313 
e14 prophage was lost, followed by an rpoB mutation and then a recD mutation along with a 314 
recN mutation. In the IR12 lineage, the primary rpoB mutation was a synonymous coding 315 
mutation. However, this did not negate a possible effect of this mutation, potentially at the level 316 
of codon usage (RpoB D1203, GAC (WT) to GAT (mutant): 0.37 to 0.63 frequency). The trend 317 
was clear in lineages IR9 and IR11, where all the mutations were non-synonymous. IR10 was the 318 
only lineage that did not conform to this trend. Although the e14 prophage did excise in lineage 319 
IR10, the sub-population that lost the prophage was outcompeted by another that maintained the 320 
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prophage and contained a variant of both RecD (N124D) and RecA (A290S). This RecA variant, 321 
A290S, was previously observed in E. coli populations evolved to resist IR (1, 2)  and also 322 
significantly contributes to electron beam IR resistance (Fig. S2). This is the only mutation 323 
observed in these four populations that appeared in the previously evolved E. coli populations, 324 
aside from loss of the e14 prophage (1, 2). After the appearance of the RecA A290S and RecD 325 
N124D variants, no RpoB variants appeared in the IR10 lineage until nearly round 40 of 326 
selection, and those variants (F15L and K1200E) had not yet reached even 50% frequency in 327 
IR10 at round 50. It appears that the evolutionary path observed in IR10 nearly occurred in 328 
population IR12 as well, where the sub-population that lost the e14 prophage was almost 329 
outcompeted by a different lineage (the competing sub-population again featuring RecD 330 
(T568A) and RecA variants (E19K)), before being carried to fixation with the apparent help of a 331 
different RecD variant (S92I). A sub-population with a RecD (W534R) and RecA variant 332 
(E286G) also reached high frequency in IR11 but was slowly outcompeted by a subpopulation 333 
with a different RecD variant (A550E) after it gained a second RpoB variant (P535L). In all of 334 
these populations, after either RpoB/RecD/RecN or RecA/RecD variants fixed, the opposing 335 
grouping of mutations did not appear within the given population. These results imply that these 336 
two evolutionary pathways confer competing yet overlapping mechanisms of IR resistance. 337 
 338 
Prominent mutations can contribute to enhanced growth phenotypes   339 
If variants of proteins such as ArcB, CopA, and DinI do not contribute to IR resistance, 340 
do they make some other contribution to fitness that explains their prominence? We have 341 
previously observed that high frequency mutations in experimentally evolved populations may 342 
contribute to enhanced growth rates, rather than IR resistance (47). Part of the selection protocol 343 
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involves an outgrowth step, after irradiation, in which mutants that grow slowly could be lost. 344 
Consistently, the ArcB N405D mutation significantly enhanced the growth phenotype of 345 
Founder Δe14 in a growth competition assay relative to the same strain with a wild-type ArcB 346 
(Fig. 11). The DinI R28H and the CopA V270F mutations had no measurable effect on growth 347 
(Fig. S3). Mutations that enhance the growth phenotype of these populations are likely 348 
important, as evidenced by their inability to grow well in media aside from LB (Fig. 6) and their 349 
inability to compete with Founder Δe14 in mixed culture without IR selection (Fig. 5). In effect, 350 
certain mutations may arise that compensate for growth defects conferred by mutations that 351 
contribute to IR resistance or deleterious, hitchhiking mutations. Founder Δe14 with the RpoB 352 
S72N and RpoC K1172I variants is outcompeted quickly by Founder Δe14 with wild-type RNA 353 
polymerase (Fig. 11). These results indicate that in order to develop high levels of IR resistance, 354 
mutations which buffer against deleterious effects on viability must also rise to prominence in 355 
these populations. Although not arising in the same genetic background, the growth phenotype of 356 
the ArcB N405D variant indicates that these populations have developed variants which can 357 
enhance growth to the degree which mutations such as the RpoB S72N/RpoC K1172I variants 358 
impede growth.  359 
 360 
Discussion 361 
It is clear that latent within the E. coli genome is a capacity for resistance to extreme 362 
doses of ionizing radiation. After 50 rounds of selection with high-energy electron beam IR, the 363 
dose required to kill 99% of each of these four replicate populations increased by over three-fold 364 
to approximately 2500 Gy (Fig. 3A). After a dose of 1500 Gy, this translates into an increase in 365 
survival of 4-5 orders of magnitude (Fig. 3B). The dose of electron beam IR that these strains 366 
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can withstand far exceeds that of previously evolved IR-resistant isolates (1, 2) , at least when 367 
the new and higher dose rate is applied. These populations vary in their growth phenotypes (Fig. 368 
3B and 4) and resistance to other forms of DNA damage (Fig. 6 and 7), indicating that they are 369 
specialized to withstand high doses of IR. 370 
Most laboratory exercises in experimental evolution have been characterized by a rapid 371 
decline in the rate of fitness increase, as fitness approaches some biologically determined 372 
optimum for a given agent of selection (22, 57, 58). One key difference between the current 373 
experiment and many other long-term directed evolution experiments is that the selection agent 374 
here is not a constant. The dose of IR inflicted on the populations increases as resistance levels 375 
increase. Increased selection pressure to meet a defined, desired phenotype throughout selection 376 
is not a novel protocol (58), yet in our evolution experiment there is no evident deceleration in 377 
the rate of fitness gains. Genetic patterns (parallelism) have allowed us to identify some key 378 
contributors to the growing IR resistance phenotype. However, the continuing advance of IR 379 
resistance and allele diversity in all populations also suggests that the pool of potential adaptive 380 
mutations is much greater than that now present in any one population. As selection continues, 381 
substantial additional gains in unique pathways may be expected. Ionizing radiation is not only a 382 
selection agent, but also a potent mutagen. Although this study was not initiated with the goal of 383 
exploring mechanisms of molecular evolution, we anticipate that the datasets provided in 384 
Supplemental Data 1 through 4 will be of use to investigators in that field.  385 
   386 
Modified DNA repair proteins and RNA polymerase enhance IR resistance 387 
Each population has traversed unique evolutionary paths to reach the same goal (Fig. 8A-388 
D). Despite varied levels of clonal interference in each population, significant genetic parallelism 389 
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in these populations allow us to identify at least some of the contributors to extreme IR 390 
resistance. In one isolate from population IR9-50, IR9-50-1, mutations in recD, recN, and 391 
rpoB/rpoC increase IR resistance of the Founder Δe14 parent-derivative. However, these variants 392 
– singly or together – do not account entirely for the IR resistance phenotype of IR9-50-1 at a 393 
dose of 1000 Gy (Fig. 9A and B). None of these genes have been previously implicated as 394 
mutational targets contributing to IR resistance (1, 2, 47).  395 
The effects of mutations in these genes reveal complex interactions. When present in an 396 
otherwise wild-type background, the mutations in recD and rpoB exhibit a clear contribution to 397 
IR resistance, although results with the recN mutation were variable.  The recD and rpoB effects 398 
were not additive, and combining them demonstrated diminishing returns epistasis. When the 399 
rpoB mutation was reverted to wild-type in the IR9-50-1 mutant background, the IR resistance 400 
phenotype was reduced little or not at all. However, reverting the recD and recN mutation to 401 
wild-type resulted in a considerable loss of IR resistance. It appears likely that a complete 402 
genetic deciphering of the IR resistance of IR9-50-1 and other isolates will require a more 403 
systematic consideration of relationships between mutations and genetic backgrounds.  404 
 Although additional contributions are clearly present, the alterations in RecD, RecN, and 405 
RpoB/RpoC (Fig. 9) provide the clearest evidence for phenotypic contributions in the current 406 
work. RecD is part of the RecBCD heterotrimer responsible for preparing ssDNA required for 407 
RecA loading, initiating homologous recombination. The RecD A90E variant is likely a loss of 408 
function mutation, as a RecD deletion in the Founder Δe14 background increases IR resistance as 409 
much as the A90E variant in this background. RecD inactivation produces a hyper-410 
recombination phenotype (59-62). Increased homologous recombination could be of significant 411 
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use to repair highly fragmented DNA post-IR, with approximately 15 DSBs generated at 1000 412 
Gy (3).  413 
 RecN is a cohesin-like protein which is involved in RecA-mediated double-strand break 414 
repair (63-66). There is little known about the precise function of RecN, though it has been 415 
implicated in maintaining proximity of broken dsDNA ends to an active RecA filament. The 416 
function of the K429Q variant is unknown, but the K429 residue is positioned in a RecN domain 417 
highly conserved among bacteria. The K429Q variant is unlikely to be a loss of function, as recN 418 
deletion greatly enhances IR sensitivity (2, 67). Further work on these RecN variants may shed 419 
new light on the function of the RecN protein. 420 
RpoB and RpoC are the beta and beta-prime subunits of RNA polymerase, respectively. 421 
Stringent mutations of RNAP, which mimic the effects of ppGpp binding and therefore the 422 
stringent response, are located primarily in RpoB and RpoC (68). Some of these stringent 423 
mutants are capable of rescuing UV-sensitivity of ruvABC mutants of E. coli, potentially due to 424 
decreased stability of contacts of RNAP with DNA (69, 70). Similar to these previous 425 
observations, the mutations in RpoB that are prevalent in our evolved populations do not locate 426 
to a single region of RpoB and therefore may affect DNA interaction throughout the DNA 427 
channel formed by RpoB/RpoC. Previously described stringent mutations L571Q and H1244Q 428 
mutants (69, 70) affect residues near those affected in the current study. These mutations likely 429 
decrease stability of RNAP on DNA and may allow for easier removal of RNAP that has stalled 430 
at a DNA lesion. Removal of stalled RNAP may be crucial for efficient DNA repair due to 431 
RNAP occluding the lesion from repair machinery or providing a major obstacle to DNA 432 
replication (71). Additionally, many stringent mutants of RNAP also confer resistance to the 433 
antibiotic Rifampicin. Mutated variants of RNAP at P535 (72) and S574 (73-75) (which have 434 
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also been isolated in this study) have previously been isolated using selection for rifampicin 435 
resistance. Although these are the first RNA polymerase mutations detected in E. coli evolved 436 
for IR resistance, similar mutants have been generated during experimental evolution of E. coli 437 
for trimethoprim and doxycycline resistance (58), heat tolerance (76, 77), growth in nutrient-438 
limited conditions (78, 79), and acid resistance (80, 81). Modifications in RNA polymerase may 439 
confer enhanced fitness throughout serial passaging, a common feature of experimental evolution 440 
studies. This advantage, combined with a potential ability to enhance DNA repair, may explain 441 
the rapid appearance of rpoB or rpoC alleles in each evolving lineage (except IR10).    442 
  443 
Excision of the e14 prophage is induced by selection for IR resistance 444 
 The only event common to each of the four populations is the excision of the e14 445 
prophage, which was evident by round two of selection. However, in lineage IR10 the 446 
subpopulation that lost e14 was outcompeted and driven extinct by cycle ten. Despite no 447 
apparent mutations within e14 that may prevent its excision, the e14 prophage remains within 448 
lineage IR10. It is unclear why e14 excision is the first clear event to happen in each population 449 
(an event that also occurred early in evolution of our previously evolved gamma-ray IR-resistant 450 
E. coli populations (1, 2). Excision of the e14 prophage is predicted to be under regulation of the 451 
SOS response,  this event may simply be an artifact of the E. coli DNA damage response (82). 452 
However, the e14 genome does encode two potentially lethal cell division inhibitor proteins: a 453 
homologue of the lambda phage protein Kil and SfiC. Loss of these proteins may itself be 454 
selective pressure. Indeed, loss of the e14 has been previously noted during experimental 455 
evolution (83) Interestingly, deletion of the e14 prophage has also been observed to cause 456 
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variable resistance to many antimicrobial agents, including increased resistance to hydrogen 457 
peroxide (84). 458 
 459 
Direct competition between two pathways to IR resistance dictates adaptation 460 
 Population sequencing also reveals the underlying competition of lineages within each 461 
population. Clonal interference is a hallmark of these populations. While much of this study 462 
focuses on the current end-point (each population after 50 cycles of selection), observing 463 
evolution over the remaining 49 cycles allows us to understand the genetic context in which new 464 
mutations arise and how the successful lineages were able to outcompete other fit, but ultimately 465 
unsuccessful, lineages. This competition within populations was almost immediately apparent. 466 
 There is an apparent competition between lineages which contain alleles of rpoB and 467 
those with recA alleles. In the current protocol, with its much higher IR dose rate, recA alleles 468 
are less common than observed in our earlier study, and novel rpoB, recD, and recN alleles 469 
predominate. In IR9, a single recA variant appeared (Y294C) but only reached approximately 470 
12% frequency in the population before being driven extinct by round 20 of selection. This 471 
population successfully lost the e14 prophage and then gained an rpoB allele followed by recD 472 
and recN alleles. The appearance of recD and recN alleles in tandem occurred in three of the four 473 
populations, and each contributes similarly to IR-resistance in a wild-type background (Fig. S4). 474 
In IR10, the RecA/RecD variant pair appears very early, and rapidly outcompetes the lineage that 475 
lost the e14 prophage. After this event, the only mutation that became fixed within the 476 
population (of those common to all four populations which we are focusing on) is another RecD 477 
variant. RpoB variants do not appear until at least round 40 of selection in IR10, and by round 478 
50, these variants do not yet appear to be on a path to fixation. No high-frequency recN allele has 479 
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appeared in IR10. The IR11 and IR12 lineages followed a path similar to that taken by IR9. In 480 
the IR11 lineage, loss of the e14 prophage and subsequent gain of an rpoB allele became fixed. 481 
In this genetic background, two separate sub-populations containing RecN/RecD and 482 
RecA/RecD variants, respectively, later reached prominence. The RecN/RecD subpopulation 483 
gained a variant of RpoB which assisted in driving this sub-population to fixation and the 484 
RecA/RecD to extinction. Finally, IR12 almost began on a similar evolutionary trajectory as 485 
IR10. A sub-population that lost the e14 prophage and gained an rpoB allele (which leads to a 486 
synonymous coding mutation) was nearly outcompeted by a RecA/RecD variant sub-population, 487 
before a RecN/RecD variant-pair rescued the sub-population that had lost e14. By round 40 of 488 
selection, the winning subpopulation reached fixation.  489 
 Despite our focus on the genetic parallelism between these four populations, it is evident 490 
that each population has begun to develop unique adaptations. Of the total number of fixation 491 
events in each lineage (excluding excision of the e14 prophage, IR9: 2; IR10: 5; IR11: 2; IR12: 492 
2) tracking mutations in rpoB/recA/recD/recN only fully accounts for such events in IR9 and 493 
IR11. In all four lineages, major subpopulations that have arisen after fixation of 494 
rpoB/recA/recD/recN combinations are completely unaccounted for by the criteria used to 495 
identify the mutations tested in this study. While it is clear that e14 excision and competition 496 
between RecA/RecD and RpoB/RecD/RecN provides a path to enhanced IR resistance, this 497 
appears to be only the first step on a complicated fitness landscape. New methods must be 498 
applied to determine the unique paths taken by each of the four lineages. 499 
 500 
Source of IR and dose rate alter the molecular basis for experimentally-evolved IR 501 
resistance 502 
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 Populations IR9-50, IR10-50, IR11-50, and IR12-50 provide us with a platform for 503 
understanding the molecular fundamentals of extreme IR resistance. These populations have 504 
been evolved using a source of IR with a much higher dose rate than that used previously to 505 
evolve IR resistance in E. coli (72 Gy/min versus 19 Gy/min) (1). Isolates from the prior evolved 506 
populations, CB2000 and CB3000 (1, 2) are only moderately more resistant to this form of IR 507 
compared to the parent strain. The higher dose rate in the current protocol may account for the 508 
relative sensitivity of the strains derived from the earlier evolution trial.  509 
 There are distinct differences in the mutations which appear in these populations and 510 
those that were previously evolved (1, 2). Only a single mutation previously noted to enhance IR 511 
resistance, RecA A290S (1), appears in the four new populations. While enhanced DNA repair is 512 
a hallmark of the previously evolved populations and the populations presented here, it appears 513 
as though the enhancements are indeed different. In addition, the frequency of transversion 514 
mutations detected in the new populations (~50% of all mutations) is far higher than that 515 
observed in the earlier studies (~20% of all mutations) (1, 55). This appears to be due to the 516 
extreme amount of detected GC to TA transitions, specifically. This transition is a hallmark of A 517 
mispairing with template-strand 8-oxodG (56), indicating that DNA damage may be more 518 
extreme in cells exposed to electron beam IR. However, the high energy electrons and gamma 519 
rays produce similar levels of killing (Fig. 1). A more likely explanation lies with the differences 520 
in the dose rate applied. In any case, these new E. coli lineages are replete with novel 521 
mechanisms of experimentally evolved IR resistance.  522 
 We do not yet have experimentally evolved E. coli that can match the natural IR 523 
resistance of the bacterium D. radiodurans. However, selection is continuing. 524 
 525 
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Materials and methods 526 
Growth conditions and bacterial strains used in this study 527 
 Unless otherwise stated, E. coli cultures were grown in Luria-Bertani (LB) broth (85) at 528 
37°C with aeration. E. coli were plated on 1.5% LB agar medium (85) and incubated at 37°C. 529 
Overnight cultures were grown in a volume of 3 mL for 16 to 18 hr. Exponential phase cultures 530 
were routinely diluted 1:100 in 10 mL of LB medium in a 50 mL Erlenmeyer flask and were 531 
grown at 37°C with shaking at 200 rpm and were harvested at an OD600 of 0.2, unless otherwise 532 
noted. After growth to an OD600 of 0.2, cultures were placed on ice for 10 min to stop growth 533 
before being used for assays. 534 
Cultures were plated on tetrazolium agar (TA) for growth competition assays when noted 535 
(48, 86). The defined rich medium EZ was mixed per manufacturer’s specifications and was 536 
supplemented with 0.2% glucose or 0.2% glycerol as indicated (Teknova; Hollister, CA). M9 537 
minimal medium (supplemented with 0.2% glucose) was used when indicated (85). 538 
All strains used for in vivo assays in this study are mutants of E. coli K-12 derivative 539 
MG1655. Genetic manipulations to transfer mutations or delete genes were performed as 540 
previously described (87, 88). Strains used in this study are listed in Table 4. 541 
Serial dilutions and CFU/mL determination 542 
All serial dilutions were performed in 1X phosphate-buffered saline (PBS) (for 1 L: 8 g 543 
NaCl, 0.2 g KCl, 1.44 g Na2HPO4, KH2PO4 0.24 g with 800 mL dH2O, adjust pH with HCl to 544 
7.4, then add remaining 200 mL dH2O). Unless otherwise stated, serial dilutions were performed 545 
with serial 1:10 dilutions of 100 µL of culture or previous dilution into 900 µL 1X PBS. Before 546 
transfer to the next dilution tube, samples were vortexed for 2 seconds and mixed by pipetting to 547 
ensure mixing. One-hundred µL of appropriate dilutions were aliquoted onto agar plates of the 548 
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appropriate medium and were spread-plated utilizing an ethanol-sterilized, bent glass rod. For 549 
spot plating, 10 µL of each dilution was aliquoted onto agar plates of the appropriate medium 550 
and spots were allowed to dry before plates were incubated as in Growth conditions.  551 
CFU/mL was calculated using the highest CFU count for each strain assayed that 552 
remained between 30 and 300 CFU (ex: 250 CFU on a 10
-4
 dilution plate would be used for 553 
calculation over 40 CFU on a 10
-5
 dilution plate).  554 
 555 
TLD dose validation 556 
An independent dose verification was performed with thermoluminescent dosimeters 557 
(TLDs). TLDs are passive dosimeters that are small, accurate and well-suited for dose 558 
verification in the routinely used 1.5 mL sample vials. For this project, three TLDs were sealed 559 
in a small plastic bag, placed into 1.5 mL tubes containing 900 µL dH2O, were placed 560 
horizontally and submerged under 1.3 cm dH2O, and irradiated as described in ‘Generalized 561 
Linac irradiation protocol’. After the vials were irradiated, the TLDs were read out in the 562 
University of Wisconsin Medical Radiation Research center (UWMRRC) TLD lab and 563 
compared to the calculated dose. Non-irradiated control TLDs were read out simultaneously to 564 
account for any background radiation. The TLDs were calibrated with a separate 
60
Co beam in 565 
the University of Wisconsin Accredited Dosimetry Calibration Laboratory (UWADCL), which 566 
provides independent National Institute of Standards and Technology (NIST) traceability for the 567 
measurements. This serves as an independent check of the ion-chamber based dose calculation 568 
method used to determine the beam-on time for this project. The estimated overall uncertainty on 569 
the TLD measured values is +/-5% with a coverage factor of k=1.  570 
 571 
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Generalized Linac irradiation protocol 572 
Samples were maintained at 4 °C and transported to the University of Wisconsin Medical 573 
Radiation Research Center (UWMRRC) Varian 21EX clinical linear accelerator (Linac) facility 574 
for irradiation. The total transport time was approximately 15 min to and from the Linac facility. 575 
For each irradiation, the Linac was set to deliver a beam of electrons with 6 MeV of energy to 576 
uniformly irradiate all samples (a total of 14) at once. To accomplish this, a special high-dose 577 
mode called HDTSe¯ was utilized, which resulted in a dose rate to the samples of approximately 578 
72 Gy/min. The sample tubes were placed horizontally and submerged at a depth of 1.3 cm 579 
(measured to the center of the tube’s volume) in an ice-water filled plastic tank and set to a 580 
source-to-surface distance (SSD) of 61.7 cm. A 30 x 30 cm
2
 square field size was set at the Linac 581 
console, which gave an effective field size at this SSD of 18.5 x 18.5 cm
2
. This is ample 582 
coverage to provide a uniform dose to all of the sample vials. The monitor unit calculations 583 
(determination of the amount of time to leave the Linac on) were based on the American 584 
Association of Physicists in Medicine (AAPM) Task Group 51 protocol for reference dosimetry 585 
(89). This is the standard method for determining dose per monitor unit in water for radiation 586 
therapy calculations. Once the dose was determined in the AAPM Task Group 51 reference 587 
protocol conditions (SSD = 100 cm and depth = 10 cm), an ion chamber and water-equivalent 588 
plastic slabs were used to translate this dose to the specific conditions used in this project 589 
 590 
Linac photon mode 591 
The Linac is designed to deliver dose with either electron or photon beams. In photon 592 
mode, the electron beam first strikes a flattening filter (not present in electron mode) to produce 593 
bremsstrahlung photons and also flatten the beam intensity profile. In order to rule out any 594 
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effective differences between electron and photon modes during irradiations, the sample vials 595 
were irradiated with the same dose rates for both modes by altering the source-to-surface-596 
distance (SSD) for each mode.   597 
 598 
Ionizing radiation resistance assay using the Linac 599 
Strains were grown in biological triplicate overnight and to an OD600 of approximately 600 
0.2 in LB as routinely performed. A 1 mL sample for each dose tested (including 0 Gy) was 601 
removed and aliquoted into a sterile 1.5 mL microfuge tube. Samples were pelleted by 602 
centrifugation at 13 xg for 1 min, and the supernatant was poured off. Samples were resuspended 603 
in 1 mL ice-cold 1X phosphate-buffered saline (PBS), and pelleting was repeated. This process 604 
was repeated three more times to wash cells. A 100µL aliquot of each culture was removed, 605 
serial diluted 1:10 in 900µL of PBS to a final 10,000-fold dilution and 100µL was plated on LB 606 
agar to determine the colony forming units (CFU)/mL before irradiation. Samples were 607 
maintained at 4 °C and irradiated with the appropriate doses as described. A 100µL aliquot of 608 
each culture was removed and plated to determine CFU/mL and percent survival as described.  609 
 610 
Directed evolution protocol using Linac 611 
For each round of directed evolution, separate aliquots of 2 mL of LB medium was 612 
inoculated with frozen stock of each population from the previous round of selection. These were 613 
incubated overnight with aeration at 37 °C and were grown with usual practices in LB medium 614 
to an OD600 of 0.2 the next day. Each culture was incubated on ice for 10 minutes to stop growth. 615 
Three 1 mL samples were removed and aliquoted into sterile 1.5 mL microfuge tubes. Samples 616 
were washed three times with 1 mL ice-cold 1X phosphate-buffered saline (PBS) and 617 
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resuspended in a final volume of 1 mL of 1X PBS. A 100µL aliquot of each culture was 618 
removed, serial diluted 1:10 in 900µL of PBS to a final 10,000-fold dilution and 100µL was 619 
plated on LB agar to determine the colony forming units (CFU)/mL before irradiation. Samples 620 
were maintained at 4 °C and taken to a Varian 21EX clinical linear accelerator (Linac) for 621 
irradiation.  622 
After irradiation, an aliquot of each culture was removed, serial diluted 1:10 in 900 µL of 623 
PBS to a final 1,000-fold dilution, and 100 µL of each serial dilution was plated on LB agar for 624 
each dose to determine the CFU/mL after irradiation. LB agar plates were incubated overnight at 625 
37 °C. Remaining irradiated cultures pelleted by centrifugation at 13 xg and supernatant was 626 
discarded. These pellets were resuspended in 1 mL of fresh LB medium, and this was added to 1 627 
mL LB medium in a 5 mL glass culture tube. These resuspensions were incubated overnight with 628 
aeration at 37 °C. The following day, the percent survival for each dose was calculated using 629 
CFU/mL calculations before and after irradiation at each dose. The overnight culture of each 630 
population replicate showing closest to 1% survival was stored at -80 °C and used for the next 631 
cycle of selection.  One cycle of selection was performed weekly due to limited access to the 632 
Linac. 633 
The initiating round of selection was done as described above, except the original culture 634 
used was an overnight culture of MG1655 prepared from an isolated colony. This protocol was 635 
adapted from a previously used protocol (1). 636 
 637 
UV Resistance Assay 638 
Cells from a single colony of each strain were cultured overnight and then grown to an 639 
OD600 of ~ 0.2 as in Growth conditions. Samples were diluted and spotted onto 25 mL 1.5% LB 640 
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agar described in the Serial dilutions. Spots were dried before the plate lid was removed and 641 
spots were exposed to the appropriate dose of UV irradiation using a Spectrolinker XL-1000 UV 642 
Crosslinker (Spectronics Corporation, Westbury,NY). Plates were imaged after incubation for 24 643 
hr. 644 
 645 
Resistance to DNA-damaging agents 646 
Cells were grown overnight and to an OD600 of approximately 0.2 in LB as routinely 647 
performed. Samples were mixed by vortexing for 5 s and were serial diluted 1:10 in 900 µl 648 
phosphate-buffered saline (PBS) to a final 100,0000-fold dilution. Ten µl was removed from 649 
each dilution and spotted onto 30mL 1.5% LB agar medium supplemented with 10 or 7.5 ng/ml 650 
ciprofloxacin hydrochloride as specified, 0.5 µM bleomycin, 4 µg/mL mitomycin C, or 5 mM 651 
hydroxyurea. Spots were dried before being incubated overnight at 37 °C. Plates were imaged 652 
after 48 hr for ciprofloxacin and bleomycin plates. 653 
 654 
Growth Competition Assay  655 
This assay was adapted from a previously published protocol (2, 48) . To differentiate 656 
strains within the competition, a fitness-neutral deletion of the araBAD operon was introduced 657 
into one of the two strains. This deletion results in red colonies on tetrazolium arabinose (TA) 658 
agar plates (48). Briefly, overnight culture of each strain to be competed were mixed 1:1, or 1:9 659 
(for growth competitions using isolates from the evolved populations after round 50 of selection 660 
or RpoB or ArcB mutations, in favor of the losing competitor) in a 1.5 mL tube. Samples were 661 
mixed by vortexing for 5 s and were serial diluted 1:10 in 900 µl phosphate-buffered saline 662 
(PBS) to a final dilution of 1:100,000. One hundred uL of the final dilution was spread plated 663 
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onto TA agar plates to assay for CFU. Seventy µl of the remaining cell mixture was used to 664 
inoculate 5 mL of fresh LB media for growth overnight. This overnight culture was used to 665 
inoculate fresh media the following day, and 100 µl was serially diluted and plated as noted 666 
above. This procedure was repeated twice more over a period of two days. The number of white 667 
versus red CFU was noted after each day of the competition and the total percentage of the 668 
culture for each competitor was determined. 669 
 670 
Deep Sequencing 671 
Genomic DNA was prepped from overnight cultures prepared from frozen stocks of 672 
populations from every even round of selection using the Wizard Genomic DNA Purification Kit 673 
(Promega, Madison, WI). DNA samples were submitted to the Department of Energy Joint 674 
Genome Institute (Walnut Creek, CA) for sequencing and analysis. DNA was randomly sheared 675 
into ~500bp fragments and the resulting fragments were used to create an Illumina library. This 676 
library was sequenced on Illumina HiSeq generating 100bp paired end reads. Reads were aligned 677 
to the reference genome using BWA (90), downsampled to an average depth of 250 fold 678 
coverage with picard (http://broadinstitute.github.io/picard) and putative mutations and small 679 
indels were called using callvariants.sh from BBMap (sourceforge.net/projects/bbmap).  680 
Sequencing results are reported in their entirety in Supplemental Data 1 through 4. 681 
However, for analysis of numbers and types of mutations in each population (and consequently 682 
for generating Fig. 8, and Table 1 through 3), mutations in genes with high homology throughout 683 
the genome (as in rrs, rrl, rrn, rhs, and ins genes) were not considered due to increased 684 
likelihood of a false-positive mutation call. In addition, mutations with inconsistent frequency 685 
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calls (ex: jumping from 0, to 100, to 0% allele frequency) were also not used. All mutations 686 
removed from consideration are also listed in Supplemental Data 1 through 4. 687 
 688 
Growth Curves 689 
Strains were cultured described as in Growth conditions  overnight and to an OD600 of 0.2 690 
in LB medium, EZ medium supplemented with 0.2% glucose (Teknova; Hollister, CA) and M9 691 
minimal medium (85) supplemented with 0.2% glucose. Cultures were then diluted 1:100 in the 692 
appropriate medium in a clear, flat bottom 96-well plate (Fisher product #: 07-200-656) and 693 
incubated overnight in a Biotek Synergy 2 plate reader (Biotek; Winooski, VT) at 37 °C with 694 
shaking, with OD600 readings taken by the plate reader every 10 minutes. 695 
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Figure Legends 991 
Fig. 1. Cell killing with electron beam versus photon beam ionizing radiation. Early 992 
exponential phase cultures of MG1655 were exposed to electron beam or photon beam IR as 993 
described in the Materials and Methods. Percent survival was determined via CFU/mL counts 994 
pre- and post-irradiation. Results are representative of a single experiment performed in 995 
biological triplicate. 996 
 997 
Fig. 2. Directed evolution scheme and lineage nomenclature. (A) Scheme. Briefly, overnight 998 
cultures were grown from a freezer stock of the parent strain/the evolved population from the 999 
previous round of selection. This overnight culture was used to inoculate fresh LB rich medium 1000 
and cultures were grown to early exponential phase. These cultures were then separated into 1001 
multiple aliquots and washed 3X in 1X PBS to remove LB medium. One aliquot of each 1002 
population was irradiated with the same dose that killed 99% of the population in the previous 1003 
round of selection, and the remaining aliquots were irradiated with higher doses. A portion of the 1004 
irradiated aliquots were plated to determine percent survival, while the remaining culture was 1005 
resuspended in fresh LB medium. These were then grown overnight, and the culture that was 1006 
nearest to 1% survival (as determined by CFU counts from pre- and post-irradiation cultures) 1007 
was stored at -80° C. One round of selection was conducted weekly due to limited access to the 1008 
Linac. (B) Nomenclature. We have generated four lineages of highly IR-resistant E. coli, 1009 
designated IR9, IR10, IR11, and IR12. A designated round of selection indicates a population at 1010 
that round (Ex: IR9-50 is lineage IR9 after 50 rounds of selection). Each population has been 1011 
stored at -80 °C as a ‘fossil record’ of evolution. Clonal isolates generated by streak plating a 1012 
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population then streak plating ten separate isolated colonies are designated by a numeral value 1013 
added to the parent population nomenclature (Ex: The first isolate from IR9-50 is IR9-50-1). 1014 
 1015 
Fig. 3. Documentation of increased IR resistance. (A) Increase in dose required to kill 99% of 1016 
cells. Each data point indicates the dose of IR that each population was given prior to being 1017 
outgrown overnight (Step 6 in Fig. 2) and stored at -80° C. (Step 7 in Fig. 2). The percent 1018 
survival was estimated from a single replicate at each round of selection. (B) Survival curves of 1019 
evolved populations compared to previously evolved Escherichia coli isolates and Deinococcus 1020 
radiodurans.  Early exponential phase cultures of the indicated strains were exposed to electron 1021 
beam IR as described in the Materials and Methods. CB2000 and CB3000 are isolates from E. 1022 
coli populations evolved to withstand γ-ray IR (1, 2). Error bars represent the standard deviation 1023 
of CFU/mL calculations from a single experiment performed in biological triplicate. 1024 
 1025 
Fig. 4. Growth curves of evolved isolates in rich and minimal medium. (A) Growth curves of 1026 
isolates in LB rich medium. (B) Growth curves of isolates in EZ defined rich medium 1027 
supplemented with 0.2% glucose. (C) Growth curves of isolates in M9 defined minimal medium 1028 
supplemented with 0.2% glucose. Cultures of indicated strains were grown in the appropriate 1029 
medium overnight and then to early exponential phase as described in the Materials and 1030 
Methods. All cultures were incubated at 37 °C during growth. Early exponential phase cultures 1031 
were diluted 1:100 in the appropriate medium, and then incubated overnight in a Biotek Synergy 1032 
2 plate reader, with OD600 measurements taken automatically every 5 minutes. Each growth 1033 
curve is a representative replicate from an experiment performed in biological triplicate. 1034 
 1035 
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Fig. 5. Growth competitions of evolved isolates. (A) Growth competition of IR9-50-1 against 1036 
Founder Δe14. (B) Growth competition of IR10-50-1 against Founder Δe14. (C) Growth 1037 
competition of IR11-50-1 against Founder Δe14. (D) Growth competition of IR12-50-1 against 1038 
Founder Δe14. Growth competitions were performed as described in the Materials and Methods. 1039 
Briefly, competitions were started with an excess of the evolved isolate so that competitions 1040 
could be carried out to 72 hr (at approximately a 9:1 ratio of evolved isolate to Founder Δe14). 1041 
Even with an excess of IR9-50-1, this isolate was outcompeted by 48 hr. Deleting the araBAD 1042 
operon causes a red colony phenotype with no fitness cost that allows for differentiation of the 1043 
two strains in competition on TA medium. IR11-50-1 is red on TA medium without alteration of 1044 
the araBAD operon, so this competition was performed against Founder Δe14 araBAD+. Error 1045 
bars represent the standard deviation of CFU/mL calculations of an experiment performed in 1046 
biological triplicate. Results shown are representative of two independent experiments.  1047 
 1048 
Fig. 6. Evolved isolates exhibit variable survival of UV irradiation. Five isolates from each 1049 
population were grown in LB medium overnight and then to early exponential phase as described 1050 
in the Materials and Methods. Cultures were serial diluted in 1X PBS, and then 10 µL of each 1051 
dilution was spot plated onto LB agar. Once spots dried, plates were exposed to UV irradiation 1052 
and were then incubated overnight before imaging. Results shown are representative of two 1053 
independent experiments performed.  1054 
 1055 
Fig. 7. Evolved isolates exhibit variable survival of various DNA damaging agents. Five 1056 
isolates from each population were grown in LB medium overnight and then to early exponential 1057 
phase as described in the Materials and Methods. Cultures were serial diluted in 1X PBS, and 1058 
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then 10 µL of each dilution was spot plated onto LB agar with the indicated DNA-damaging 1059 
agent. Once spots dried the plates were then incubated overnight before imaging. Results shown 1060 
are representative of two independent experiments performed.  1061 
 1062 
Fig. 8. Mutations in evolving populations. (A-D) Allele frequencies as a function of selection 1063 
round. Panels A-D reflect the indicated population, IR9, IR10, IR11, and IR12, respectively. 1064 
Whole populations at each even round of selection were deep-sequenced by the Joint Genome 1065 
Institute (JGI) as described in the Materials and Methods. Every mutation that reached at least 1066 
2% frequency at some point in a single population are depicted as single lines. The sole black 1067 
line in each graph represents the loss of the e14 prophage. Mutations that reach a frequency of 1068 
“1.00” are fixed, and subsequent mutations occur within that genetic background. The y-axis 1069 
represents the allele frequency of each single mutation within the population (i.e. a mutation at 1070 
0.5 is in 50% of the isolates in the population). The x-axis represents the round of selection. 1071 
Allele frequency data was generated from every even cycle of selection. Graphs were generated 1072 
using the R library “ggplot2”. Line colors are utilized primarily to allow ready distinctions 1073 
between subpopulations, but otherwise have no significance. Data used to generate these plots 1074 
are contained within Supplemental Data 1 through 4. (E) Number of mutations over rounds of 1075 
selection in evolving populations. Each data point represents the total number of detected 1076 
mutations at or above 2% frequency in each sequenced whole population. The number of 1077 
mutations generally increases, but experience dips as major sub-populations are driven to 1078 
extinction. Data used to generate this plot are contained within Supplemental Data 1 through 4. 1079 
 1080 
49 
 
Fig. 9. Mutations which contribute to IR resistance in the evolved isolate IR9-50-1. (A) IR 1081 
resistance of Founder Δe14 derivatives containing mutations from lineage IR9. Mutations were 1082 
moved singly or in combination from IR9-50-1 (in the case of ArcB N405D, from IR9-20-1; the 1083 
recD deletion was made in the Founder Δe14 parent strain) into the Founder Δe14 strain 1084 
background as described in the Materials and Methods. A ‘+’ symbol indicates that the variant is 1085 
present in that strain. (B) IR resistance of IR9-50-1 derivatives containing reversions of 1086 
mutations to the wild-type sequence. Wild-type sequences of the gene encoding the indicated 1087 
protein variants was moved from Founder Δe14 into IR9-50-1 as described in the Materials and 1088 
Methods (IR9-50-1 does not have a ArcB variant, therefore no reversion was tested in this 1089 
strain). A ‘-’  symbol indicates that the variant was reverted to the wild-type allele in that strain. 1090 
Each strain was assayed for IR resistance alongside biological triplicate of the parent strain (a 1091 
Founder Δe14 or IR9-50-1 control) and the average percent survival of the experimental strains 1092 
was compared to that of the parent strain. All strains were exposed to 1000 Gy of electron beam 1093 
IR and percent survival was determined via calculating CFU/mL before and after irradiation. 1094 
Error bars represent the standard deviation of CFU/mL calculations of at least two independent 1095 
experiments performed in biological triplicate. Statistical significance of percent survival relative 1096 
to the parent strain was determined using a two-tailed Student’s T-test. The ‘*’ and ‘***’ 1097 
represent p-values of < 0.05 and < 0.001, respectively. 1098 
 1099 
Fig. 10. Frequencies of mutations implicated in IR resistance over rounds of selection. 1100 
Frequencies of mutations in genes implicated in evolved IR resistance (rpoB, recA, recD, recN ) 1101 
and the loss of the e14 prophage are depicted. Both synonymous and non-synonymous mutations 1102 
are included. These data seemingly indicate two separate paths to acquiring IR resistance: loss of 1103 
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the e14 prophage, gain of an rpoB, then recD, then recN mutation, in that order (IR9, IR11, 1104 
IR12), or gain of a recA and recD mutation in concert (IR10). In lineages IR11 and IR12, these 1105 
two pathways to IR resistance appear in direct competition, with the rpoB, recD, and recN path 1106 
being the apparent ‘winner’. Data used to generate these plots are contained within Supplemental 1107 
Data 1 through 4. 1108 
 1109 
Fig. 11. Effects of prevalent mutations on growth. Two mutations from lineage IR9 have 1110 
opposite effects on growth; ArcB N405D greatly enhances growth of Founder Δe14 whereas the 1111 
RpoB S72N/RpoC K1172I mutations greatly hinder growth. These results suggest that mutation 1112 
not seen to affect IR resistance (ArcB N405D) may be selected for in these populations to 1113 
counteract the deleterious growth effects of mutations which enhance IR resistance. Growth 1114 
competition assays were performed as described in the Materials and Methods. Initial ratios of 1115 
each strain were purposefully mixed at 9 (loser):1 (winner) so that growth competition assays 1116 
could be carried out for longer than 24 hr. Results shown are representative of two independent 1117 
experiments performed. 1118 
 1119 
 1120 
 1121 
 1122 
 1123 
 1124 
 1125 
 1126 
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Tables 1127 
 1128 
Table 1. Number and types of mutations in evolved populations after 50 cycles of selection. 1129 
Mutations in coding regions that likely cause loss of function of the protein product (single and 1130 
double base insertions/deletions, gain or loss of stop codons, and loss of start codons) appeared 1131 
in each population. However, IR9-50 had the most predicted loss of function mutations (72) 1132 
compared to the other three populations (IR10-50: 48, IR11-50: 40, IR12-50: 49). Of these 1133 
mutations in all populations, -1 frameshift mutations were the most common, followed by 1134 
introduced stop codons.  1135 
 1136 
Table 2. Mutations that are likely candidates for enhancing IR resistance. Proteins listed are 1137 
encoded by genes that have i) mutations that were non-synonymous; ii) mutations that occurred 1138 
in a gene that was mutated in at least two additional populations; iii) mutations that achieved at 1139 
least 10% abundance at some point during selection in each population in which they appeared; 1140 
and iv) the mutation remained in the population at round 50 of selection. The mutations in RecA 1141 
and Nth were included as these are the only proteins with the same variant present in two 1142 
populations. The bolded variants are fixed in the indicated population, the variants listed in black 1143 
are present above 2% frequency at round 50 of selection, and variants listed in gray were present 1144 
in the indicated lineage but have been driven extinct by round 50 of selection. 1145 
 1146 
Table 3. Number of mutations in isolates from evolved populations after 50 cycles of 1147 
selection. Nomenclature of the isolates indicates the lineage (ex: IR9) and round of selection 1148 
(ex:50) from which the isolate was derived. The remaining numeral distinguishes the individual 1149 
52 
 
isolates.  1150 
 1151 
Table 4. List of strains used in this study. Strains generated in this study were constructed as 1152 
described in the Materials and Methods. A ‘wt’ designation indicates that the protein is variant at 1153 
the indicated allele in the evolved isolate but has been swapped to the wild-type (MG1655) 1154 
allele. The ‘*’ symbol indicates that this nucleotide position is in reference to the NCBI 1155 
GenBank U00096.3 reference genome. 1156 
 1157 
 1158 
  1159 
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Table 1 1160 
 1161 
  1162 
Parent bp Mutant bp IR9-50 IR10-50 IR11-50 IR12-50
AT GC 93 106 94 110
GC AT 180 158 130 223
AT CG 26 17 11 25
GC TA 154 116 84 143
AT TA 81 58 59 85
GC CG 41 25 31 51
273 264 224 333
302 216 185 304
575 480 409 637
127 124 98 171
340 275 237 363
2.68 2.22 2.42 2.12
29 15 12 16
1 2 0 1
0 0 1 2
+1 1 2 2 3
+2 0 0 0 0
+3 0 0 1 0
+12 0 0 1 0
-1 40 26 21 26
-2 0 1 1 2
-3 1 0 0 0
81 70 65 92
+1 0 0 0 0
+2 0 0 0 1
+3 0 0 0 0
-1 3 6 4 6
-2 0 0 0 1
-3 0 0 0 0
107 84 20 76
242 109 130 150
309 199 205 320
620 515 439 676
T
ra
n
s
v
e
rs
io
n
s
Transitions
Insertions
Synonymous
Transversions
Transitions
Total
N
o
n
-c
o
d
in
g
C
o
d
in
g
Insertions
Deletions
SNPs
Start lost
Stop lost
Stop gained
dN/dS
Non-synonymous
Deletions
A
lle
le
 
fr
e
q
u
e
n
c
ie
s Fixed (>99%)
>50%
>10 %
>2%
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Table 2 1163 
 1164 
  1165 
Pathway Protein IR9 IR10 IR11 IR12
Anaerobic 
respiration
ArcB N405D
D166Y 
S280R 
L90 fs 
Y71C
R100H 
S74W
S24P 
K547 fs
Copper 
metabolism
CopA V270F T525A A812V
DinI
R28H 
P14A
W71* I66N S26Y
Nth
C203Y 
E160K 
C203Y 
K85N
RecA Y294C A290S
A290S 
E286G 
E19K
RecD
A90E 
L188* 
L223* 
P99*
N124D 
Q463* 
L301M
A550E 
A39G 
C71 fs 
G307W 
W534R 
S92I 
A271E 
C103* 
T568A
RecN
K429Q 
E271G 
R118L
F144L
R102P 
S382R
A361T 
R285C 
R368H 
S310L
RNA 
polymerase
RpoB
S72N 
S391P
F15L 
K1200E
P535L 
S574F 
 T600I 
D
N
A
 m
e
ta
b
o
lis
m
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Table3 1166 
 1167 
  1168 
Isolate Number of Mutations
IR9-50-1 312
IR9-50-2 298
IR9-50-3 299
IR9-50-4 314
IR9-50-5 322
IR10-50-1 184
IR10-50-2 188
IR10-50-3 197
IR10-50-4 210
IR10-50-5 191
IR11-50-1 200
IR11-50-2 192
IR11-50-3 194
IR11-50-4 182
IR11-50-5 197
IR12-50-1 280
IR12-50-2 241
IR12-50-3 245
IR12-50-4 232
IR12-50-5 237
56 
 
Table 4 1169 
 1170 Strain Relevant Genotype Source
MG1655
YbhJ L54I + MntP G25D + RIP321 A 4296380* ACG + GlpR C 3560455* 
CG + GatC ACC 2173360* A
Blattner, 1997
EAW7704          
(Founder Δe14)
MG1655 Δe14 + RbsR L92R + CytR Q110 stop +  fabI /ycjD int (G 
1351174* A) + yifN /ppiC  int (T 3959934* C) 
Harris, 2009
IR9-50 MG1655 exposed to 50 iterative rounds of IR; mixed population This study
IR10-50 MG1655 exposed to 50 iterative rounds of IR; mixed population This study
IR11-50 MG1655 exposed to 50 iterative rounds of IR; mixed population This study
IR12-50 MG1655 exposed to 50 iterative rounds of IR; mixed population This study
IR9-50-1 Isolate from IR9-50 This study
IR9-50-2 Isolate from IR9-50 This study
IR9-50-3 Isolate from IR9-50 This study
IR9-50-4 Isolate from IR9-50 This study
IR9-50-5 Isolate from IR9-50 This study
IR10-50-1 Isolate from IR10-50 This study
IR10-50-2 Isolate from IR10-50 This study
IR10-50-3 Isolate from IR10-50 This study
IR10-50-4 Isolate from IR10-50 This study
IR10-50-5 Isolate from IR10-50 This study
IR11-50-1 Isolate from IR11-50 This study
IR11-50-2 Isolate from IR11-50 This study
IR11-50-3 Isolate from IR11-50 This study
IR11-50-4 Isolate from IR11-50 This study
IR11-50-5 Isolate from IR11-50 This study
IR12-50-1 Isolate from IR12-50 This study
IR12-50-2 Isolate from IR12-50 This study
IR12-50-3 Isolate from IR12-50 This study
IR12-50-4 Isolate from IR12-50 This study
IR12-50-5 Isolate from IR12-50 This study
CB2000 Isolate from IR-resistant evolved population IR-2-20 Harris, 2009
CB3000 Isolate from IR-resistant evolved population IR-3-20 Harris, 2009
EAW792 Founder Δe14 + ArcB N405D This study
EAW971 Founder Δe14 + CopA V270F This study
EAW766 Founder Δe14 + DinI R28H This study
JDT56 Founder Δe14 + RecA A290S This study
EAW726 Founder Δe14 + RecD A90E This study
EAW725 Founder Δe14 + RecN K429Q This study
EAW756 Founder Δe14 + RpoB S72N/RpoC K1172I This study
EAW748 Founder Δe14 + RecD A90E + RecN K428H This study
EAW904 Founder Δe14 + RecD A90E + RpoB S72N/RpoC K1172I This study
EAW781 Founder Δe14 + RecD A90E + RecN K428H + RpoB S72N/RpoC K1172I This study
EAW972 IR9-50-1 + CopA V270 wt This study
EAW1047 IR9-50-1 + DinI R28 wt This study
EAW973 IR9-50-1 + RecD A90 wt This study
EA1024 IR9-50-1 + RecN K429 wt This study
EAW981 IR9-50-1 + RpoB S72/RpoC K1172 wt This study
EAW1021 IR9-50-1 + RecD A90 wt + RpoB S72/RpoC K1172 wt This study
EAW1046 IR9-50-1 + RecD A90 wt + RpoB S72/RpoC K1172 wt + RecN K429 wt This study
STB75 Founder Δe14 ΔaraBAD Bruckbauer, 2018
* nucleotide position compared to NCBI GenBank U00096.3 reference sequence











